The invention relates to a pharmaceutical formulation for oral administration, the formulation containing an effective quantity of Vardenafil hydrochloride or Vardenafil hydrochloride trihydrate, stearic acid and at least one further pharmaceutically acceptable excipient. A further solution provides a process for the preparation of said formulation.